C20orf202
gene geneOn this page
Summary
C20orf202 (chromosome 20 open reading frame 202, HGNC:37254) is a protein-coding gene on chromosome 20p13, encoding Uncharacterized protein C20orf202 (A1L168).
At a glance
- Clinical variants (ClinVar): 6 total — 1 pathogenic
- MANE Select transcript:
NM_001394958
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:37254 |
| Approved symbol | C20orf202 |
| Name | chromosome 20 open reading frame 202 |
| Location | 20p13 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000215595 |
| Ensembl biotype | protein_coding |
| Entrez | 400831 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000400633
RefSeq mRNA: 1 — MANE Select: NM_001394958
NM_001394958
CCDS: CCDS46567
Canonical transcript exons
ENST00000400633 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001544012 | 1206869 | 1209076 |
| ENSE00001544013 | 1203454 | 1203651 |
Expression profiles
Bgee: expression breadth ubiquitous, 117 present calls, max score 87.44.
Top tissues by expression
124 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 87.44 | gold quality |
| placenta | UBERON:0001987 | 67.15 | gold quality |
| right lung | UBERON:0002167 | 66.44 | gold quality |
| apex of heart | UBERON:0002098 | 63.93 | gold quality |
| gall bladder | UBERON:0002110 | 58.32 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 58.04 | gold quality |
| islet of Langerhans | UBERON:0000006 | 58.00 | gold quality |
| lung | UBERON:0002048 | 57.11 | gold quality |
| cerebellum | UBERON:0002037 | 56.02 | gold quality |
| cerebellar cortex | UBERON:0002129 | 55.98 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 55.98 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 55.36 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 55.29 | gold quality |
| heart left ventricle | UBERON:0002084 | 55.23 | gold quality |
| prefrontal cortex | UBERON:0000451 | 54.75 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 54.33 | gold quality |
| muscle of leg | UBERON:0001383 | 53.55 | gold quality |
| gastrocnemius | UBERON:0001388 | 53.41 | gold quality |
| adipose tissue | UBERON:0001013 | 53.27 | gold quality |
| substantia nigra | UBERON:0002038 | 53.17 | gold quality |
| amygdala | UBERON:0001876 | 52.65 | gold quality |
| temporal lobe | UBERON:0001871 | 52.62 | gold quality |
| colonic epithelium | UBERON:0000397 | 52.34 | silver quality |
| skin of leg | UBERON:0001511 | 52.01 | gold quality |
| duodenum | UBERON:0002114 | 51.98 | gold quality |
| omental fat pad | UBERON:0010414 | 51.98 | gold quality |
| heart | UBERON:0000948 | 51.96 | gold quality |
| frontal cortex | UBERON:0001870 | 51.92 | gold quality |
| lymph node | UBERON:0000029 | 51.87 | gold quality |
| hypothalamus | UBERON:0001898 | 51.80 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.61 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
55 targeting C20orf202, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-7110-3P | 100.00 | 73.18 | 2486 |
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-128-3P | 99.95 | 71.17 | 2484 |
| HSA-MIR-216A-3P | 99.95 | 71.19 | 2505 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-4753-3P | 99.90 | 71.03 | 3786 |
| HSA-MIR-3681-3P | 99.88 | 70.46 | 2254 |
| HSA-MIR-30A-3P | 99.87 | 69.74 | 2928 |
| HSA-MIR-30D-3P | 99.87 | 69.92 | 2917 |
| HSA-MIR-30E-3P | 99.87 | 69.68 | 2942 |
| HSA-MIR-6844 | 99.82 | 70.69 | 2423 |
| HSA-MIR-3150A-3P | 99.76 | 64.44 | 1640 |
| HSA-MIR-6763-5P | 99.76 | 64.68 | 1767 |
| HSA-MIR-3659 | 99.70 | 67.97 | 694 |
| HSA-MIR-3175 | 99.65 | 66.30 | 2031 |
| HSA-MIR-542-3P | 99.34 | 67.58 | 1270 |
| HSA-MIR-4652-3P | 99.33 | 70.02 | 2742 |
| HSA-MIR-6731-5P | 99.28 | 67.42 | 2375 |
| HSA-MIR-8085 | 99.28 | 67.56 | 2362 |
| HSA-MIR-7974 | 99.24 | 65.48 | 1137 |
| HSA-MIR-593-3P | 99.22 | 67.28 | 1327 |
| HSA-MIR-4279 | 99.19 | 66.70 | 2437 |
| HSA-MIR-323B-3P | 99.14 | 68.89 | 725 |
| HSA-MIR-7702 | 99.06 | 65.95 | 698 |
| HSA-MIR-6814-5P | 99.03 | 66.68 | 1273 |
| HSA-MIR-361-5P | 98.95 | 70.16 | 1340 |
| HSA-MIR-760 | 98.81 | 66.65 | 1392 |
| HSA-MIR-210-5P | 98.57 | 64.37 | 832 |
| HSA-MIR-4722-5P | 98.46 | 66.34 | 1611 |
| HSA-MIR-1910-3P | 98.44 | 67.51 | 1695 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Tmem74bos | ENSMUSG00000087035 |
| rattus_norvegicus | Tmem74bos | ENSRNOG00000064629 |
Paralogs (3): FAM167A (ENSG00000154319), FAM167B (ENSG00000183615), AARD (ENSG00000205002)
Protein
Protein identifiers
Uncharacterized protein C20orf202 — A1L168 (reviewed: A1L168)
All UniProt accessions (1): A1L168
UniProt curated annotations — full annotation on UniProt →
RefSeq proteins (1): NP_001381887* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR051771 | FAM167_domain | Family |
UniProt features (2 total): chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A1L168-F1 | 74.33 | 0.41 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 10 (showing top):
GSE12366_GC_BCELL_VS_PLASMA_CELL_DN, GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_UP, GSE15659_RESTING_TREG_VS_NONSUPPRESSIVE_TCELL_UP, GSE15659_RESTING_VS_ACTIVATED_TREG_UP, chr20p13, DESCARTES_FETAL_CEREBELLUM_VASCULAR_ENDOTHELIAL_CELLS, DESCARTES_FETAL_CEREBRUM_VASCULAR_ENDOTHELIAL_CELLS, GSE37416_CTRL_VS_0H_F_TULARENSIS_LVS_NEUTROPHIL_UP, GSE23114_WT_VS_SLE2C1_MOUSE_PERITONEAL_CAVITY_B1A_BCELL_DN, GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_IN_SLE2C1_MOUSE_DN
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
Protein interactions and networks
STRING
10 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| C20orf202 | WASHC3 | Q9Y3C0 | 0 |
| C20orf202 | CCDC102B | Q68D86 | 0 |
| C20orf202 | SNAPIN | O95295 | 0 |
| C20orf202 | MAPRE1 | Q15691 | 0 |
| C20orf202 | HNRNPCL1 | O60812 | 0 |
IntAct
25 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| C20orf202 | HNRNPCL1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| C20orf202 | MAPRE1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| C20orf202 | WASHC3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| C20orf202 | CCDC102B | psi-mi:“MI:0915”(physical association) | 0.560 |
| C20orf202 | ABI2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| C20orf202 | SGF29 | psi-mi:“MI:0915”(physical association) | 0.560 |
| C20orf202 | SNAPIN | psi-mi:“MI:0915”(physical association) | 0.560 |
| C20orf202 | MAPRE3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HNRNPCL1 | C20orf202 | psi-mi:“MI:0915”(physical association) | 0.000 |
| MAPRE1 | C20orf202 | psi-mi:“MI:0915”(physical association) | 0.000 |
| WASHC3 | C20orf202 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CCDC102B | C20orf202 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ABI2 | C20orf202 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SGF29 | C20orf202 | psi-mi:“MI:0915”(physical association) | 0.000 |
| MAPRE3 | C20orf202 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SNAPIN | C20orf202 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (8): C20orf202 (Two-hybrid), C20orf202 (Two-hybrid), C20orf202 (Two-hybrid), C20orf202 (Two-hybrid), C20orf202 (Two-hybrid), C20orf202 (Two-hybrid), C20orf202 (Two-hybrid), C20orf202 (Two-hybrid)
ESM2 similar proteins: A1L168, A1L3T7, A6NGS2, A6QQF7, D4A8G3, O15049, P0C7N2, P0C7N4, P17257, P58660, Q08AY9, Q0V7M8, Q0VDN7, Q14BJ1, Q2NL23, Q3KP66, Q3LUD3, Q3UNU4, Q4LEZ3, Q566R4, Q571B6, Q5BJW5, Q5ND29, Q5RFZ7, Q5XIS1, Q6NSJ2, Q6P1G6, Q6Q0N2, Q7TN12, Q7TSI1, Q811W1, Q8BL43, Q8C7U1, Q8IV03, Q8K1S6, Q8K2P1, Q8N137, Q8N5H3, Q8TE77, Q8WWL2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
6 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 5 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 150565 | GRCh38/hg38 20p13(chr20:80093-1246766)x1 | Pathogenic |
SpliceAI
361 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 20:1206867:A:AG | acceptor_gain | 0.9900 |
| 20:1206868:G:GG | acceptor_gain | 0.9900 |
| 20:1206868:GTCT:G | acceptor_gain | 0.9900 |
| 20:1203648:GCTG:G | donor_gain | 0.9800 |
| 20:1206802:G:T | donor_gain | 0.9800 |
| 20:1206867:AGTCT:A | acceptor_gain | 0.9700 |
| 20:1206868:GTCTG:G | acceptor_gain | 0.9700 |
| 20:1203651:GGT:G | donor_loss | 0.9600 |
| 20:1203653:T:TC | donor_loss | 0.9600 |
| 20:1206868:GTC:G | acceptor_gain | 0.9600 |
| 20:1206773:G:GG | donor_gain | 0.9500 |
| 20:1206868:GT:G | acceptor_gain | 0.9500 |
| 20:1206772:A:AG | donor_gain | 0.9400 |
| 20:1206864:CCTA:C | acceptor_loss | 0.9300 |
| 20:1206865:CTA:C | acceptor_loss | 0.9300 |
| 20:1206867:A:C | acceptor_loss | 0.9300 |
| 20:1203654:A:C | donor_loss | 0.9200 |
| 20:1203652:G:GG | donor_gain | 0.9100 |
| 20:1206869:TCTG:T | acceptor_gain | 0.9000 |
| 20:1206864:CCTAG:C | acceptor_gain | 0.8900 |
| 20:1206788:A:G | donor_gain | 0.8700 |
| 20:1206865:CTAG:C | acceptor_gain | 0.8700 |
| 20:1206866:TAGTC:T | acceptor_gain | 0.8700 |
| 20:1206863:TCCTA:T | acceptor_gain | 0.8500 |
| 20:1206871:TG:T | acceptor_gain | 0.8500 |
| 20:1206867:AG:A | acceptor_gain | 0.8400 |
| 20:1206868:G:T | acceptor_gain | 0.8200 |
| 20:1207021:C:T | donor_gain | 0.8200 |
| 20:1206855:CTTCT:C | acceptor_loss | 0.7700 |
| 20:1207073:G:T | donor_gain | 0.7300 |
AlphaMissense
786 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 20:1203638:T:C | L41P | 0.981 |
| 20:1206918:T:C | L62P | 0.980 |
| 20:1206876:T:C | M48T | 0.978 |
| 20:1206877:G:A | M48I | 0.976 |
| 20:1206877:G:C | M48I | 0.976 |
| 20:1206877:G:T | M48I | 0.976 |
| 20:1203650:T:C | L45P | 0.969 |
| 20:1206888:A:C | D52A | 0.969 |
| 20:1206897:T:C | L55P | 0.969 |
| 20:1206909:T:C | L59P | 0.963 |
| 20:1206888:A:T | D52V | 0.960 |
| 20:1206887:G:C | D52H | 0.945 |
| 20:1203634:T:A | W40R | 0.932 |
| 20:1203634:T:C | W40R | 0.932 |
| 20:1203642:A:C | R42S | 0.929 |
| 20:1203642:A:T | R42S | 0.929 |
| 20:1203636:G:C | W40C | 0.928 |
| 20:1203636:G:T | W40C | 0.928 |
| 20:1206939:T:C | L69P | 0.926 |
| 20:1206889:T:A | D52E | 0.921 |
| 20:1206889:T:G | D52E | 0.921 |
| 20:1203647:A:T | E44V | 0.917 |
| 20:1206876:T:G | M48R | 0.916 |
| 20:1206930:T:C | L66P | 0.906 |
| 20:1203648:G:C | E44D | 0.896 |
| 20:1203648:G:T | E44D | 0.896 |
| 20:1206900:T:C | L56P | 0.896 |
| 20:1203629:T:C | L38S | 0.892 |
| 20:1203647:A:G | E44G | 0.890 |
| 20:1203638:T:A | L41Q | 0.880 |
dbSNP variants (sampled 300 via entrez): RS1000142386 (20:1205897 A>C), RS1001094902 (20:1205261 A>C), RS1001317348 (20:1207369 A>G), RS1001927821 (20:1201538 T>C), RS1002095376 (20:1203343 G>A,C), RS1002166397 (20:1209102 C>T), RS1002992594 (20:1209346 C>A), RS1003038987 (20:1204143 A>G), RS1003106708 (20:1208821 T>C), RS1003650103 (20:1203755 G>A,C,T), RS1003869216 (20:1202151 A>G), RS1003942512 (20:1204008 G>A,T), RS1004337819 (20:1208782 C>A), RS1004445719 (20:1205495 T>C), RS1005048564 (20:1207050 G>A,C,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
3 total (human), top 3 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cadmium Chloride | decreases expression, increases abundance, increases expression | 2 |
| Cadmium | increases abundance, increases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.